Scott Schorer

GI Dynamics, Inc. engages in the development and commercialization of a medical device system intended for treatment of patients with type 2 diabetes and reduction of obesity. Its pipeline product is EndoBarrier, an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. The company was founded by Andy Levine on March 24, 2003 and is headquartered in Boston, MA.

Innovative Spinal Technologies, Inc. (IST) develops spinal technology products and surgical protocols. Its products include Axient, Paramount PSS, Paramount VBR, and Cordant ACP. The company was founded in 2002 by Stephen Hochschuler and Barton Sachs and is headquartered in Mansfield, MA.

Carl Zeiss AG engages in the development and manufacture of scientific optics technologies and solutions services. Its products and solutions inlcude medical, microscopy, optemetry, industrial metrology spectroscopy, semicondictor technology, camera and film lenses, and simulation solutions planetariums. The company was founded by Carl Zeiss in 1846 and is headquartered in Oberkochen, Germany.

Global Healthcare Exchange, Inc. provides web-based business-to-business solutions that streamline information and commerce. The company is based in Westminster, CO. The company was founded by Robert Bernard Stockman, Scott W. Schorer. Global Healthcare Exchange was acquired by Global Healthcare Exchange LLC on September 28, 2000 for $15.20 million.

Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC.

Part of Johnson & Johnson, Systagenix Wound Management US, Inc. is a private company that manufactures and distributes pharmaceutical preparations. The company is based in Warren, NJ.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The private company is based in Washington. The CEO of the American company is Mark A. Augusti.

Gila Therapeutics, Inc. provides developing therapies for obesity patients. The company was founded by Sergei Zolotukhin and Andres Acosta in January 2014 and is headquartered in Excelsior, MN.